Rezolute (RZLT) Current Leases (2014 - 2026)
Rezolute recorded quarterly Current Leases of $673000.0 in Q1 2026, up 1.05% quarter-over-quarter from $666000.0 in Q4 2025, and up 9.43% year-over-year from $615000.0 in Q1 2025.
Rezolute's Current Leases history runs 11 years deep, the most recent figure standing at $673000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 9.43% year-over-year to $673000.0; the TTM figure through Mar 2026 stood at $673000.0 (up 9.43% YoY), while the FY2025 annual figure was $632000.0, up 11.27% from the prior year.
- Current Leases came in at $673000.0 for Q1 2026 at Rezolute, up from $666000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $673000.0 in Q1 2026 to a low of $107000.0 in Q1 2022.
- A 5-year average of $468000.0 and a median of $552000.0 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases plunged 66.67% in 2022 and surged 400.93% in 2023, its largest moves.
- Rezolute's Current Leases stood at $167000.0 in 2022, then soared by 222.16% to $538000.0 in 2023, then increased by 11.34% to $599000.0 in 2024, then gained by 11.19% to $666000.0 in 2025, then climbed by 1.05% to $673000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $673000.0, $666000.0, and $650000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 673,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673,000.00 |
| Dec 31, 2025 | 666,000.00 |
| Sep 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 599,000.00 |
| Sep 30, 2024 | 584,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 538,000.00 |
| Sep 30, 2023 | 525,000.00 |
| Jun 30, 2023 | 541,000.00 |
| Mar 31, 2023 | 319,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Sep 30, 2022 | 112,000.00 |
| Jun 30, 2022 | 108,000.00 |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | 147,000.00 |
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 265,000.00 |
| Mar 31, 2021 | 321,000.00 |
| Dec 31, 2020 | 316,000.00 |
| Sep 30, 2020 | 245,000.00 |
| Jun 30, 2020 | 245,000.00 |
| Mar 31, 2020 | 245,000.00 |
| Dec 31, 2019 | 239,000.00 |
| Sep 30, 2019 | 234,000.00 |
| Jun 30, 2016 | 23,128.00 |
| Mar 31, 2016 | 46,946.00 |
| Dec 31, 2015 | 70,526.00 |
| Sep 30, 2015 | 93,870.00 |
| Jun 30, 2015 | 93,852.00 |
| Mar 31, 2015 | 92,912.00 |
| Dec 31, 2014 | 91,817.00 |
| Sep 30, 2014 | 83,182.00 |